ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FX04 | BioTech | Ipilimumab - 50mg/10ml | 7938 | 80114/1 | YERVOY | 50mg/10ml | 1x10ml | Injectable solution | Infusion | Pacific pharma | Baxter Pharmaceutical Solutions LLC | USA | 5,634,152 L.L | 2.44 | E2 | Bristol-Myers Squibb Company | USA | 1/4/2023 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FX04 | BioTech | Ipilimumab - 50mg/10ml | 7938/945 | 80114/1 | YERVOY | 50mg/10ml | 1x10ml | Injectable solution | Infusion | Pacific pharma | Baxter Pharmaceutical Solutions LLC | USA | 230,275,887 L.L | 2.44 | E2 | Bristol-Myers Squibb Company | USA | 1/4/2023 |